Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 4,175.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 6,215
  • Market Cap: £217.49m

Latest ShareCast News

Bioventix revenue rises in tougher first half

By Josh White

Date: Monday 29 Mar 2021

(Sharecast News) - Diagnostic antibody developer Bioventix reported a 1.3% improvement in revenue in its first half on Monday, to £5.2m.

Bioventix appoints Bruce Hiscox as chief financial officer

By Iain Gilbert

Date: Wednesday 01 Jul 2020

(Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.

Bioventix full-year revenue and profits improve

By Josh White

Date: Monday 21 Oct 2019

(Sharecast News) - Bioventix, which specialises in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, reported a 6% improvement in revenue for the year on Monday, to £9.3m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,175.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,500.00
52 Week Low 3,800.00
Volume 6,215
Shares Issued 5.21m
Market Cap £217.49m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.84% below the market average86.84% below the market average86.84% below the market average86.84% below the market average86.84% below the market average
80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average
Price Trend
26.95% below the market average26.95% below the market average26.95% below the market average26.95% below the market average26.95% below the market average
25.42% below the sector average25.42% below the sector average25.42% below the sector average25.42% below the sector average25.42% below the sector average
Income Not Available
Growth
77.06% above the market average77.06% above the market average77.06% above the market average77.06% above the market average77.06% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 18-Jun-2021

Time Volume / Share Price
16:03 1,000 @ 4,150.00p
16:33 150 @ 4,175.00p
14:26 1,681 @ 4,200.00p
15:11 300 @ 4,165.00p
15:02 34 @ 4,200.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page